Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.
2.

Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.

Ishimitsu T, Numabe A, Masuda T, Akabane T, Okamura A, Minami J, Matsuoka H.

Hypertens Res. 2009 Nov;32(11):962-8. doi: 10.1038/hr.2009.133. Epub 2009 Aug 21.

PMID:
19696778
3.
5.
6.

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.

Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A; FEVER Study Group.

J Hypertens. 2005 Dec;23(12):2157-72.

PMID:
16269957
7.

Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators.

Uzu T, Harada T, Namba T, Yamamoto R, Takahara K, Yamauchi A, Kimura G.

J Hypertens. 2005 Apr;23(4):861-5.

PMID:
15775792
8.

Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.

Ohnishi K, Kohno M, Yukiiri K, Masugata H, Wada Y, Takagi Y, Ohmori K.

Int J Clin Pharmacol Ther. 2001 Oct;39(10):417-22.

PMID:
11680666
9.

Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.

Arch Intern Med. 2005 Apr 25;165(8):936-46.

PMID:
15851647
10.

Long-term evaluation of combined antihypertensive therapy with lisinopril and a thiazide diuretic in patients with essential hypertension.

Ishimitsu T, Yagi S, Ebihara A, Doi Y, Domae A, Shibata A, Kimura M, Sugishita Y, Sagara E, Sakamaki T, Murata K.

Jpn Heart J. 1997 Nov;38(6):831-40.

PMID:
9486936
11.
13.

Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes.

Schneider M, Lerch M, Papiri M, Buechel P, Boehlen L, Shaw S, Risen W, Weidmann P.

J Hypertens. 1996 May;14(5):669-77.

PMID:
8762212
15.

Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic.

Takami T.

Hypertens Res. 2009 Dec;32(12):1086-90. doi: 10.1038/hr.2009.156. Epub 2009 Sep 25.

PMID:
19779491
16.

Molecular effects of M17055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats.

Kim S, Hamaguchi A, Shinkawa T, Kato Y, Tsuchiya N, Miura K, Ohta K, Iwao H.

J Pharmacol Exp Ther. 1996 Nov;279(2):983-90.

PMID:
8930208
18.

Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension.

Sato K, Dohi Y, Kojima M, Miyagawa K, Takase H, Katada E, Suzuki S.

Arzneimittelforschung. 2006;56(7):535-40.

PMID:
16927536
19.

Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension.

Suzuki R, Fukuda N, Katakawa M, Tsunemi A, Tahira Y, Matsumoto T, Ueno T, Soma M.

Am J Hypertens. 2014 May;27(5):695-701. doi: 10.1093/ajh/hpt208. Epub 2013 Nov 7.

PMID:
24200748
20.

Effects of chlorthalidone and diltiazem on myocardial ischemia in elderly patients with hypertension and coronary artery disease.

Serro-Azul JB, de Paula RS, Gruppi C, Pinto L, Pierri H, Nussbacher A, Gebara O, Moffa P, Pereira-Barreto AC, Wajngarten M.

Arq Bras Cardiol. 2001 Apr;76(4):268-72.

Supplemental Content

Support Center